MOLN:NASDAQ
Molecular Partners AG
$4.20
arrow_upward
+4.48%(+0.18) 1D
Set 15, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa MOLN...
Buksan
$3.99
Mataas
$4.20
Mababa
$3.90
Mkt. cap
169.02M
Avg. na dami
1.18K
Dami
0.00
Mataas nang 52-wk
$5.36
Mababa nang 52-wk
$3.53
EPS
-$1.68
Beta
1.02
Mga natitirang share
40.38M
Bilang ng mga empleyado
134
Buksan
$3.99
Mataas
$4.20
Mababa
$3.90
Mkt. cap
169.02M
Avg. na dami
1.18K
Dami
0.00
Mataas nang 52-wk
$5.36
Mababa nang 52-wk
$3.53
EPS
-$1.68
Beta
1.02
Mga natitirang share
40.38M
Bilang ng mga empleyado
134
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
Tungkol sa Molecular Partners AG